Association of polymorphisms in apolipoprotein A1 and apolipoprotein B genes with lipid profile in Tamilian population

Indian Heart Journal

Volumn 61, Issue 1, 2009, Pages 51-54

  Padmaja, N ^a   Ravindra Kumar, M ^a   Adithan, C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

ApoAI; ApoB; Lipid levels; PCR RFLP; Tamilian

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENOTYPE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 66949113669     PISSN: 00194832     EISSN: 00194832     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Jeenah M, Kessling A, Miller N, Humphries SE. G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Mol Biol Med. 1990;7:233-241 (Pubitemid 20283936)
2. Al-Yahyaee SA, Al-Kindi MN, Al-Bahrani AI. Apolipoprotein A1 gene polymorphisms at the -75 bp and +83/ 84 bp polymorphic sites in healthy Omanis compared with world populations. Hum Biol 2004; 76(2):307-312 (Pubitemid 39014219)
3. Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res 2006; 124(3):235-244 (Pubitemid 44734280)
4. Hughes K, Lun KC, Yeo PP. Cardiovascular diseases in Chinese, Malays, and Indians in Singapore. I. Differences in mortality. J Epidemiol Community Health 1990; 44(1):24-28
5. Wang XL, Liu SX, McCredie RM, Wilcken DE. Polymorphisms at the 5′-end of the apolipoprotein AI gene and severity of coronary artery disease. J Clin Invest 1996; 98(2):372-377 (Pubitemid 26255736)
6. Pan JP, Chiang AN, Tai JJ, et al. Restriction fragment length polymorphisms of apolipoprotein B gene in Chinese population with coronary heart disease. Clin Chem 1995; 41(3):424-429
7. Heng CK, Low PS, Saha N. Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore. Pediatr Res 2001; 49(4):514-518 (Pubitemid 32274965)
8. Puri RD, Tewari S, Sinha N et al. Polymorphisms in the apolipoprotein B-100 gene: association with plasma lipid concentration and coronary artery disease. Indian Heart J 2003; 55(1):60-64 (Pubitemid 36582685)
9. Choong ML, Sethi SK, Koay ES. Effects of intragenic variability at 3′ polymorphic sites of the apolipoprotein B gene on serum lipids and lipoproteins in a multiethnic Asian population. Hum Biol 1999; 71(3):381-397 (Pubitemid 29257230)
10. Machado MO, Hirata MH, Bertolami MC, Hirata RD. Apo B gene haplotype is associated with lipid profile of higher risk for coronary heart disease in Caucasian Brazilian men. J Clin Lab Anal 2001; 15(1):19-24. (Pubitemid 32157421)
11. Wang XL, Badenhop R, Humphrey KE, Wilcken DE. New MspI polymorphism at +83 bp of the human apolipoprotein AI gene: association with increased circulating high density lipoprotein cholesterol levels. Genet Epidemiol 1996; 13(1):1-10.
12. Lahoz C, Pena R, Mostaza JM et al. Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapy. Atherosclerosis 2003;168(2): 289-295. (Pubitemid 36703328)